Nanopharm, a division of Aptar Pharma, is a leading global specialized contract research organization (CRO) that offers services for the design and development of orally inhaled and nasal drug products (OINDPs). Operating on a fee-for-service basis, Nanopharm assists clients in overcoming scientific, technical, and regulatory challenges associated with the development of nasal and respiratory drug products from initial discovery to clinical investigations (‘IND’). Through its comprehensive range of services, Nanopharm facilitates an efficient and integrated drug development process, including advanced product design, formulation development, and clinical trials support.
Products & Services
Sites
Nanopharm Ltd.
Country
United KingdomCity
Cwmbran
Address
Grange Road, NP44 3WY